Skip to main content

The M&A Advisor Recognizes Mintz Transaction as $50 - 100 Million "Cross Border Deal of the Year"

The M&A Advisor has recognized the acquisition of Cambrooke Therapeutics by Ajinomoto Co. Inc. as “Cross Border Deal of the Year ($50 – 100M).” Mintz served as legal counsel for Cambrooke.

The deal is one in a variety of categories being recognized by the 10th Annual International M&A Awards. Other categories include: “Cross Border M&A Deal of the Year,” “Corporate/Strategic Acquisition of the Year,” “Cross Border Restructuring of the Year, Financing of the Year,” “Sector Deals of the Year,” and “Regional Deals of the Year,” among others. The awards will be presented at the annual gala on June 18, 2018 at the Princeton Club in New York.

Cambrooke is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. Ajinomoto is a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals.

The Mintz deal team was led by Member Greg Fine and Attorney Rob Giacchetti.